speb/financial-data huggingface dataset:
PPLI cash_flow (quarterly, 2025-12-31) — Earnings Losses From Equity Investments: -118527000.00
PPLI cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: 759000.00
PPLI cash_flow (quarterly, 2025-12-31) — Effect Of Exchange Rate Changes: 108000.00
PPLI cash_flow (annual, 2025-12-31) — End Cash Position: 986831000.00
PPLI cash_flow (quarterly, 2025-12-31) — End Cash Position: 986831000.00
PPLI cash_flow (annual, 2025-12-31) — Financing Cash Flow: -465346000.00
PPLI cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -31869000.00
PPLI cash_flow (annual, 2025-12-31) — Free Cash Flow: 42076000.00
PPLI cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 31365000.00
PPLI cash_flow (annual, 2025-12-31) — Gain Loss On Sale Of Business: 17675000.00
PPLI income_statement (annual, 2025-12-31) — Gain On Sale Of Security: 101500000.00
PPLI income_statement (quarterly, 2025-12-31) — Gain On Sale Of Security: 100852000.00
PPLI balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -11842000.00
PPLI balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -11842000.00
PPLI income_statement (annual, 2025-12-31) — General And Administrative Expense: 418523000.00
PPLI income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 105987000.00
PPLI balance_sheet (annual, 2025-12-31) — Goodwill: 1791475000.00
PPLI balance_sheet (quarterly, 2025-12-31) — Goodwill: 1791475000.00
PPLI balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 2257335000.00
PPLI balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 2257335000.00
PPLI balance_sheet (annual, 2025-12-31) — Gross Accounts Receivable: 458798000.00
PPLI balance_sheet (quarterly, 2025-12-31) — Gross Accounts Receivable: 458798000.00
PPLI balance_sheet (annual, 2025-12-31) — Gross PPE: 486046000.00
PPLI balance_sheet (quarterly, 2025-12-31) — Gross PPE: 486046000.00
PPLI income_statement (annual, 2025-12-31) — Gross Profit: 1583424000.00
PPLI income_statement (quarterly, 2025-12-31) — Gross Profit: 450925000.00
PPLI income_statement (annual, 2025-12-31) — Impairment Of Capital Assets: 207451000.00
PPLI income_statement (annual, 2025-12-31) — Interest Expense: 120027000.00
PPLI income_statement (quarterly, 2025-12-31) — Interest Expense: 26910000.00
PPLI income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 120027000.00
PPLI income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 26910000.00
PPLI income_statement (annual, 2025-12-31) — Interest Income: 46580000.00
PPLI income_statement (quarterly, 2025-12-31) — Interest Income: 9425000.00
PPLI income_statement (annual, 2025-12-31) — Interest Income Non Operating: 46580000.00
PPLI income_statement (quarterly, 2025-12-31) — Interest Income Non Operating: 9425000.00
PPLI cash_flow (annual, 2025-12-31) — Interest Paid Supplemental Data: 115584000.00
PPLI balance_sheet (annual, 2025-12-31) — Invested Capital: 6159651000.00
PPLI balance_sheet (quarterly, 2025-12-31) — Invested Capital: 6159651000.00
PPLI cash_flow (annual, 2025-12-31) — Investing Cash Flow: -417114000.00
PPLI cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -33454000.00
PPLI balance_sheet (annual, 2025-12-31) — Investmentin Financial Assets: 409240000.00
PPLI balance_sheet (quarterly, 2025-12-31) — Investmentin Financial Assets: 409240000.00
PPLI balance_sheet (annual, 2025-12-31) — Investments And Advances: 2811098000.00
PPLI balance_sheet (quarterly, 2025-12-31) — Investments And Advances: 2811098000.00
PPLI balance_sheet (annual, 2025-12-31) — Investmentsin Associatesat Cost: 2401858000.00
PPLI balance_sheet (quarterly, 2025-12-31) — Investmentsin Associatesat Cost: 2401858000.00
PPLI cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 400000000.00
PPLI cash_flow (annual, 2025-12-31) — Issuance Of Debt: 991451000.00
PPLI cash_flow (quarterly, 2025-12-31) — Issuance Of Debt: -400000000.00
PPLI balance_sheet (annual, 2025-12-31) — Land And Improvements: 86045000.00
PPLI balance_sheet (quarterly, 2025-12-31) — Land And Improvements: 86045000.00
PPLI balance_sheet (annual, 2025-12-31) — Leases: 76936000.00
PPLI balance_sheet (quarterly, 2025-12-31) — Leases: 76936000.00
PPLI balance_sheet (annual, 2025-12-31) — Liabilities Heldfor Sale Non Current: 0.00
PPLI balance_sheet (quarterly, 2025-12-31) — Liabilities Heldfor Sale Non Current: 0.00
PPLI balance_sheet (annual, 2025-12-31) — Long Term Debt: 1401324000.00
PPLI balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 1401324000.00
PPLI balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 1401324000.00
PPLI balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 1401324000.00
PPLI cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 991451000.00
PPLI cash_flow (quarterly, 2025-12-31) — Long Term Debt Issuance: -400000000.00
PPLI cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -1434523000.00
PPLI cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: -4375000.00
PPLI balance_sheet (annual, 2025-12-31) — Long Term Equity Investment: 2401858000.00
PPLI balance_sheet (quarterly, 2025-12-31) — Long Term Equity Investment: 2401858000.00
PPLI balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 36240000.00
PPLI balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 36240000.00
PPLI balance_sheet (annual, 2025-12-31) — Minority Interest: 55196000.00
PPLI balance_sheet (quarterly, 2025-12-31) — Minority Interest: 55196000.00
PPLI income_statement (annual, 2025-12-31) — Minority Interests: -2556000.00
PPLI income_statement (quarterly, 2025-12-31) — Minority Interests: -996000.00
PPLI cash_flow (annual, 2025-12-31) — Net Business Purchase And Sale: 11359000.00
PPLI cash_flow (quarterly, 2025-12-31) — Net Business Purchase And Sale: 388066000.00
PPLI cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: 84959000.00
PPLI cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: 384959000.00
PPLI balance_sheet (annual, 2025-12-31) — Net Debt: 465613000.00
PPLI balance_sheet (quarterly, 2025-12-31) — Net Debt: 465613000.00
PPLI income_statement (annual, 2025-12-31) — Net Income: -104026000.00
PPLI income_statement (quarterly, 2025-12-31) — Net Income: -76794000.00
PPLI income_statement (annual, 2025-12-31) — Net Income Common Stockholders: -104026000.00
PPLI income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: -76794000.00
PPLI income_statement (annual, 2025-12-31) — Net Income Continuous Operations: -116757000.00
PPLI income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: -75772000.00
PPLI income_statement (annual, 2025-12-31) — Net Income Discontinuous Operations: 15287000.00
PPLI income_statement (quarterly, 2025-12-31) — Net Income Discontinuous Operations: -26000.00
PPLI income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -104026000.00
PPLI income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -76794000.00
PPLI income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -119313000.00
PPLI income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -76768000.00
PPLI cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: -116757000.00
PPLI cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: -75772000.00
PPLI income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: -101470000.00
PPLI income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: -75798000.00
PPLI income_statement (annual, 2025-12-31) — Net Interest Income: -73447000.00
PPLI income_statement (quarterly, 2025-12-31) — Net Interest Income: -17485000.00
PPLI cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: -26077000.00
PPLI cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: -38025000.00
PPLI cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: -443072000.00
PPLI cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: -404375000.00
PPLI cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: -443072000.00
PPLI cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: -404375000.00
PPLI income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -73447000.00
PPLI income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -17485000.00
PPLI cash_flow (annual, 2025-12-31) — Net Other Financing Charges: -92890000.00
PPLI cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: -12453000.00
PPLI cash_flow (annual, 2025-12-31) — Net Other Investing Changes: -1591000.00
PPLI cash_flow (quarterly, 2025-12-31) — Net Other Investing Changes: -4922000.00
PPLI balance_sheet (annual, 2025-12-31) — Net PPE: 287393000.00
PPLI balance_sheet (quarterly, 2025-12-31) — Net PPE: 287393000.00
PPLI cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: 17458000.00
PPLI cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: 13203000.00
PPLI balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 2476492000.00
PPLI balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 2476492000.00
PPLI balance_sheet (annual, 2025-12-31) — Non Current Deferred Liabilities: 148602000.00
PPLI balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Liabilities: 148602000.00
PPLI balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Liabilities: 148602000.00
PPLI balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Liabilities: 148602000.00
PPLI income_statement (annual, 2025-12-31) — Normalized EBITDA: 293883000.00
PPLI income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 135033000.00
PPLI income_statement (annual, 2025-12-31) — Normalized Income: -20452400.00
PPLI income_statement (quarterly, 2025-12-31) — Normalized Income: -18037030.00
PPLI cash_flow (annual, 2025-12-31) — Operating Cash Flow: 61277000.00
PPLI cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 36578000.00
PPLI cash_flow (annual, 2025-12-31) — Operating Gains Losses: -101500000.00
PPLI cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: -119697000.00
PPLI income_statement (annual, 2025-12-31) — Operating Income: 110035000.00
PPLI income_statement (quarterly, 2025-12-31) — Operating Income: 94082000.00
PPLI income_statement (annual, 2025-12-31) — Operating Revenue: 2393189000.00
PPLI income_statement (quarterly, 2025-12-31) — Operating Revenue: 645979000.00
PPLI balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 77344499.00
PPLI balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 77344499.00
PPLI balance_sheet (annual, 2025-12-31) — Other Current Assets: 95988000.00
PPLI balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 95988000.00
PPLI balance_sheet (annual, 2025-12-31) — Other Current Liabilities: 207244000.00
PPLI balance_sheet (quarterly, 2025-12-31) — Other Current Liabilities: 207244000.00
PPLI balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: -11842000.00
PPLI balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: -11842000.00
PPLI income_statement (annual, 2025-12-31) — Other Gand A: 418523000.00
PPLI income_statement (quarterly, 2025-12-31) — Other Gand A: 105987000.00
PPLI income_statement (annual, 2025-12-31) — Other Income Expense: -118497000.00
PPLI income_statement (quarterly, 2025-12-31) — Other Income Expense: -74068000.00
PPLI balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 465860000.00
PPLI balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 465860000.00
PPLI cash_flow (annual, 2025-12-31) — Other Non Cash Items: 25368000.00
PPLI cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: -3234000.00
PPLI balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 230153000.00
PPLI balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 230153000.00
PPLI balance_sheet (annual, 2025-12-31) — Other Non Current Liabilities: 230913000.00
PPLI balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 230913000.00
PPLI income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: 6643000.00
PPLI income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 275000.00
PPLI balance_sheet (annual, 2025-12-31) — Other Properties: 114132000.00
PPLI balance_sheet (quarterly, 2025-12-31) — Other Properties: 114132000.00
PPLI income_statement (annual, 2025-12-31) — Other Special Charges: 19189000.00
PPLI income_statement (quarterly, 2025-12-31) — Other Special Charges: -13411000.00
PPLI income_statement (annual, 2025-12-31) — Otherunder Preferred Stock Dividend: 0.00
PPLI income_statement (quarterly, 2025-12-31) — Otherunder Preferred Stock Dividend: 0.00
PPLI balance_sheet (annual, 2025-12-31) — Payables: 37519000.00
PPLI balance_sheet (quarterly, 2025-12-31) — Payables: 37519000.00
PPLI balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 37519000.00
PPLI balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 37519000.00
PPLI balance_sheet (annual, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 133681000.00
PPLI balance_sheet (quarterly, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 133681000.00
PPLI balance_sheet (annual, 2025-12-31) — Prepaid Assets: 39737000.00
PPLI balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 39737000.00
PPLI income_statement (annual, 2025-12-31) — Pretax Income: -81909000.00
PPLI income_statement (quarterly, 2025-12-31) — Pretax Income: 2529000.00
PPLI balance_sheet (annual, 2025-12-31) — Properties: 0.00
PPLI balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
PPLI cash_flow (annual, 2025-12-31) — Purchase Of Investment: -40011000.00
PPLI cash_flow (quarterly, 2025-12-31) — Purchase Of Investment: -40011000.00
PPLI balance_sheet (annual, 2025-12-31) — Receivables: 448814000.00
PPLI balance_sheet (quarterly, 2025-12-31) — Receivables: 448814000.00
PPLI income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 809765000.00
PPLI income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 195054000.00
PPLI income_statement (annual, 2025-12-31) — Reconciled Depreciation: 130625000.00
PPLI income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 31251000.00
PPLI cash_flow (annual, 2025-12-31) — Repayment Of Debt: -1434523000.00
PPLI cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -4375000.00
PPLI cash_flow (annual, 2025-12-31) — Repurchase Of Capital Stock: -315041000.00
PPLI cash_flow (quarterly, 2025-12-31) — Repurchase Of Capital Stock: -15041000.00
PPLI income_statement (annual, 2025-12-31) — Research And Development: 196021000.00
PPLI income_statement (quarterly, 2025-12-31) — Research And Development: 46497000.00
PPLI balance_sheet (annual, 2025-12-31) — Retained Earnings: -643000000.00
PPLI balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -643000000.00
PPLI cash_flow (annual, 2025-12-31) — Sale Of Business: 11359000.00
PPLI cash_flow (quarterly, 2025-12-31) — Sale Of Business: 1503000.00
PPLI cash_flow (annual, 2025-12-31) — Sale Of Investment: 13934000.00
PPLI cash_flow (quarterly, 2025-12-31) — Sale Of Investment: 1986000.00
PPLI cash_flow (annual, 2025-12-31) — Sale Of PPE: 17458000.00
PPLI cash_flow (quarterly, 2025-12-31) — Sale Of PPE: 13203000.00
PPLI income_statement (annual, 2025-12-31) — Selling And Marketing Expense: 728220000.00
PPLI income_statement (quarterly, 2025-12-31) — Selling And Marketing Expense: 173108000.00
PPLI income_statement (annual, 2025-12-31) — Selling General And Administration: 1146743000.00
PPLI income_statement (quarterly, 2025-12-31) — Selling General And Administration: 279095000.00
PPLI balance_sheet (annual, 2025-12-31) — Share Issued: 89370499.00
PPLI balance_sheet (quarterly, 2025-12-31) — Share Issued: 89370499.00
PPLI income_statement (annual, 2025-12-31) — Special Income Charges: -226640000.00
PPLI income_statement (quarterly, 2025-12-31) — Special Income Charges: -175195000.00
PPLI cash_flow (annual, 2025-12-31) — Stock Based Compensation: 32313000.00
PPLI cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 16246000.00
PPLI balance_sheet (annual, 2025-12-31) — Stockholders Equity: 4733827000.00
PPLI balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 4733827000.00
PPLI balance_sheet (annual, 2025-12-31) — Tangible Book Value: 2476492000.00
PPLI balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 2476492000.00
PPLI income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: -26279400.00
PPLI income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: -15612030.00
PPLI income_statement (annual, 2025-12-31) — Tax Provision: 34848000.00
PPLI income_statement (quarterly, 2025-12-31) — Tax Provision: 78301000.00
PPLI income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.21
PPLI income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.21
PPLI balance_sheet (annual, 2025-12-31) — Total Assets: 7130729000.00
PPLI balance_sheet (quarterly, 2025-12-31) — Total Assets: 7130729000.00
PPLI balance_sheet (annual, 2025-12-31) — Total Capitalization: 6135151000.00
PPLI balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 6135151000.00
PPLI balance_sheet (annual, 2025-12-31) — Total Debt: 1425824000.00
PPLI balance_sheet (quarterly, 2025-12-31) — Total Debt: 1425824000.00
PPLI balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 4789023000.00
PPLI balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 4789023000.00
PPLI income_statement (annual, 2025-12-31) — Total Expenses: 2283154000.00
PPLI income_statement (quarterly, 2025-12-31) — Total Expenses: 551897000.00
PPLI balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 2341706000.00
PPLI balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 2341706000.00
PPLI balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 5585979000.00
PPLI balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 5585979000.00
PPLI balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 1780839000.00
PPLI balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 1780839000.00
PPLI income_statement (annual, 2025-12-31) — Total Operating Income As Reported: -97416000.00
PPLI income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: -113369000.00
PPLI income_statement (annual, 2025-12-31) — Total Unusual Items: -125140000.00
PPLI income_statement (quarterly, 2025-12-31) — Total Unusual Items: -74343000.00
PPLI income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: -125140000.00
PPLI income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: -74343000.00
PPLI balance_sheet (annual, 2025-12-31) — Treasury Shares Number: 12026000.00
PPLI balance_sheet (quarterly, 2025-12-31) — Treasury Shares Number: 12026000.00
PPLI balance_sheet (annual, 2025-12-31) — Treasury Stock: 571032000.00
PPLI balance_sheet (quarterly, 2025-12-31) — Treasury Stock: 571032000.00
PPLI balance_sheet (annual, 2025-12-31) — Working Capital: 983883000.00
PPLI balance_sheet (quarterly, 2025-12-31) — Working Capital: 983883000.00
PPLI income_statement (quarterly, 2026-03-31) — +Operating Expense: 303186000.00
PPLI income_statement (quarterly, 2026-03-31) — +Total Revenue: 422893000.00
PPLI balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 35815000.00
PPLI balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 328772000.00
PPLI balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 5974269000.00
PPLI income_statement (quarterly, 2026-03-31) — Amortization: 19040000.00
PPLI cash_flow (quarterly, 2026-03-31) — Amortization Cash Flow: 19040000.00
PPLI cash_flow (quarterly, 2026-03-31) — Amortization Of Intangibles: 19040000.00
PPLI income_statement (quarterly, 2026-03-31) — Amortization Of Intangibles Income Statement: 19040000.00
PPLI balance_sheet (quarterly, 2026-03-31) — Assets Held For Sale Current: 0.00
PPLI balance_sheet (quarterly, 2026-03-31) — Available For Sale Securities: 404628000.00
PPLI income_statement (quarterly, 2026-03-31) — Basic Average Shares: 76742000.00
PPLI income_statement (quarterly, 2026-03-31) — Basic EPS: -0.94
PPLI cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 986831000.00
PPLI cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -7961000.00
PPLI cash_flow (quarterly, 2026-03-31) — Capital Expenditure Reported: -7961000.00
PPLI balance_sheet (quarterly, 2026-03-31) — Capital Stock: 9000.00
PPLI balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 1112445000.00
PPLI balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 1112445000.00
PPLI cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: -141152000.00
PPLI cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: 260644000.00
PPLI cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: 9964000.00
PPLI cash_flow (quarterly, 2026-03-31) — Cash From Discontinued Financing Activities: 0.00
PPLI cash_flow (quarterly, 2026-03-31) — Cash From Discontinued Investing Activities: -60000.00
PPLI cash_flow (quarterly, 2026-03-31) — Cash From Discontinued Operating Activities: 5424000.00
PPLI cash_flow (quarterly, 2026-03-31) — Change In Account Payable: -61564000.00
PPLI cash_flow (quarterly, 2026-03-31) — Change In Other Current Assets: -940000.00
PPLI cash_flow (quarterly, 2026-03-31) — Change In Other Current Liabilities: -14545000.00
PPLI cash_flow (quarterly, 2026-03-31) — Change In Other Working Capital: 1912000.00
PPLI cash_flow (quarterly, 2026-03-31) — Change In Payable: -61564000.00
PPLI cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: -61564000.00
PPLI cash_flow (quarterly, 2026-03-31) — Change In Receivables: 86268000.00
PPLI cash_flow (quarterly, 2026-03-31) — Change In Working Capital: 11131000.00
PPLI cash_flow (quarterly, 2026-03-31) — Changes In Account Receivables: 86268000.00
PPLI cash_flow (quarterly, 2026-03-31) — Changes In Cash: 134820000.00
PPLI balance_sheet (quarterly, 2026-03-31) — Common Stock: 9000.00
PPLI balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 4549452000.00
PPLI cash_flow (quarterly, 2026-03-31) — Common Stock Payments: -123574000.00
PPLI income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 159773000.00
PPLI balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 338544000.00
PPLI balance_sheet (quarterly, 2026-03-31) — Current Assets: 1550621000.00
PPLI balance_sheet (quarterly, 2026-03-31) — Current Debt: 24500000.00
PPLI balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 24500000.00
PPLI balance_sheet (quarterly, 2026-03-31) — Current Deferred Liabilities: 20923000.00
PPLI balance_sheet (quarterly, 2026-03-31) — Current Deferred Revenue: 20923000.00
PPLI balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 419782000.00
PPLI cash_flow (quarterly, 2026-03-31) — Deferred Income Tax: -15121000.00
PPLI cash_flow (quarterly, 2026-03-31) — Deferred Tax: -15121000.00
PPLI cash_flow (quarterly, 2026-03-31) — Depreciation: 7314000.00
PPLI cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 26354000.00
PPLI income_statement (quarterly, 2026-03-31) — Depreciation Amortization Depletion Income Statement: 26354000.00
PPLI cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 26354000.00
PPLI income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 26354000.00
PPLI income_statement (quarterly, 2026-03-31) — Depreciation Income Statement: 7314000.00
PPLI income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 76742000.00
PPLI income_statement (quarterly, 2026-03-31) — Diluted EPS: -0.94
PPLI income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: -71882000.00
PPLI cash_flow (quarterly, 2026-03-31) — Dividends Received Cfi: 0.00
PPLI income_statement (quarterly, 2026-03-31) — EBIT: 8028000.00
PPLI income_statement (quarterly, 2026-03-31) — EBITDA: 34382000.00
PPLI cash_flow (quarterly, 2026-03-31) — Earnings Losses From Equity Investments: -34005000.00
PPLI cash_flow (quarterly, 2026-03-31) — Effect Of Exchange Rate Changes: -1411000.00
PPLI cash_flow (quarterly, 2026-03-31) — End Cash Position: 1120240000.00
PPLI cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: -141152000.00
PPLI cash_flow (quarterly, 2026-03-31) — Free Cash Flow: 7427000.00
PPLI cash_flow (quarterly, 2026-03-31) — Gain Loss On Investment Securities: 4574000.00
PPLI cash_flow (quarterly, 2026-03-31) — Gain Loss On Sale Of PPE: -7500000.00
PPLI income_statement (quarterly, 2026-03-31) — Gain On Sale Of Security: 29431000.00
PPLI balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: -14054000.00
PPLI income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 104107000.00
PPLI balance_sheet (quarterly, 2026-03-31) — Goodwill: 1507911000.00
PPLI balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 1883252000.00
PPLI income_statement (quarterly, 2026-03-31) — Gross Profit: 263120000.00
PPLI income_statement (quarterly, 2026-03-31) — Interest Expense: 25858000.00
PPLI income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 25858000.00
PPLI income_statement (quarterly, 2026-03-31) — Interest Income: 9529000.00
PPLI income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 9529000.00
PPLI balance_sheet (quarterly, 2026-03-31) — Invested Capital: 5969726000.00
PPLI cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: 260584000.00
PPLI balance_sheet (quarterly, 2026-03-31) — Investmentin Financial Assets: 404628000.00
PPLI balance_sheet (quarterly, 2026-03-31) — Investments And Advances: 2877723000.00
PPLI balance_sheet (quarterly, 2026-03-31) — Investmentsin Associatesat Cost: 2473095000.00
PPLI balance_sheet (quarterly, 2026-03-31) — Liabilities Heldfor Sale Non Current: 0.00
PPLI balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 1395774000.00
PPLI balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 1395774000.00
PPLI cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: -6125000.00
PPLI balance_sheet (quarterly, 2026-03-31) — Long Term Equity Investment: 2473095000.00
PPLI balance_sheet (quarterly, 2026-03-31) — Minority Interest: 45233000.00
PPLI income_statement (quarterly, 2026-03-31) — Minority Interests: -1212000.00
PPLI cash_flow (quarterly, 2026-03-31) — Net Business Purchase And Sale: 295697000.00
PPLI cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: -123574000.00
PPLI balance_sheet (quarterly, 2026-03-31) — Net Debt: 307829000.00
PPLI income_statement (quarterly, 2026-03-31) — Net Income: -71882000.00
PPLI income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: -71882000.00
PPLI income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: -2252000.00
PPLI income_statement (quarterly, 2026-03-31) — Net Income Discontinuous Operations: 7225000.00
PPLI income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 3761000.00
PPLI income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: -3464000.00
PPLI cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: -2252000.00
PPLI income_statement (quarterly, 2026-03-31) — Net Income From Tax Loss Carryforward: -75643000.00
PPLI income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: -70670000.00
PPLI cash_flow (quarterly, 2026-03-31) — Net Intangibles Purchase And Sale: 7500000.00
PPLI income_statement (quarterly, 2026-03-31) — Net Interest Income: -16329000.00
PPLI cash_flow (quarterly, 2026-03-31) — Net Investment Purchase And Sale: -37194000.00
PPLI cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: -6125000.00
PPLI cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: -6125000.00
PPLI income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -16329000.00
PPLI cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: -11453000.00
PPLI cash_flow (quarterly, 2026-03-31) — Net Other Investing Changes: 2602000.00
PPLI balance_sheet (quarterly, 2026-03-31) — Net PPE: 285630000.00
PPLI balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 2666200000.00
PPLI balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Liabilities: 192966000.00
PPLI balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 192966000.00
PPLI income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 4951000.00
PPLI income_statement (quarterly, 2026-03-31) — Normalized Income: -21122600.00
PPLI cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: 15388000.00
PPLI cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: -36931000.00
PPLI income_statement (quarterly, 2026-03-31) — Operating Income: -40066000.00
PPLI income_statement (quarterly, 2026-03-31) — Operating Revenue: 422893000.00
PPLI balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 74562499.00
PPLI balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 109404000.00
PPLI balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: -14054000.00
PPLI income_statement (quarterly, 2026-03-31) — Other Gand A: 104107000.00
PPLI income_statement (quarterly, 2026-03-31) — Other Income Expense: 38565000.00
PPLI balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 375341000.00
PPLI cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: 10371000.00
PPLI balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 222991000.00
PPLI balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 217010000.00
PPLI income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 9134000.00
PPLI balance_sheet (quarterly, 2026-03-31) — Payables: 35815000.00
PPLI balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 374359000.00
PPLI income_statement (quarterly, 2026-03-31) — Pretax Income: -17830000.00
PPLI cash_flow (quarterly, 2026-03-31) — Purchase Of Investment: -37232000.00
PPLI balance_sheet (quarterly, 2026-03-31) — Receivables: 328772000.00
PPLI income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 159773000.00
PPLI income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 26354000.00
PPLI cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -6125000.00
PPLI cash_flow (quarterly, 2026-03-31) — Repurchase Of Capital Stock: -123574000.00
PPLI income_statement (quarterly, 2026-03-31) — Research And Development: 39695000.00
PPLI balance_sheet (quarterly, 2026-03-31) — Retained Earnings: -714882000.00
PPLI cash_flow (quarterly, 2026-03-31) — Sale Of Business: 295697000.00
PPLI cash_flow (quarterly, 2026-03-31) — Sale Of Intangibles: 7500000.00
PPLI cash_flow (quarterly, 2026-03-31) — Sale Of Investment: 38000.00
PPLI income_statement (quarterly, 2026-03-31) — Selling And Marketing Expense: 133030000.00
PPLI income_statement (quarterly, 2026-03-31) — Selling General And Administration: 237137000.00
PPLI balance_sheet (quarterly, 2026-03-31) — Share Issued: 89872499.00
PPLI cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 16412000.00
PPLI balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 4549452000.00
PPLI balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 2666200000.00
PPLI income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 11772400.00
PPLI income_statement (quarterly, 2026-03-31) — Tax Provision: -15578000.00
PPLI income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.40
PPLI balance_sheet (quarterly, 2026-03-31) — Total Assets: 6820217000.00
PPLI balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 5945226000.00
PPLI balance_sheet (quarterly, 2026-03-31) — Total Debt: 1420274000.00
PPLI balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 4594685000.00
PPLI income_statement (quarterly, 2026-03-31) — Total Expenses: 462959000.00
PPLI balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 2225532000.00
PPLI balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 5269596000.00
PPLI balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 1805750000.00
PPLI income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: -40066000.00
PPLI income_statement (quarterly, 2026-03-31) — Total Unusual Items: 29431000.00
PPLI income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: 29431000.00
PPLI balance_sheet (quarterly, 2026-03-31) — Treasury Shares Number: 15310000.00
PPLI balance_sheet (quarterly, 2026-03-31) — Treasury Stock: 695890000.00
PPLI balance_sheet (quarterly, 2026-03-31) — Working Capital: 1130839000.00
PPLPHARMA.NS balance_sheet (annual, 2022-03-31) — Accumulated Depreciation: -15354400000.00
PPLPHARMA.NS balance_sheet (annual, 2022-03-31) — Additional Paid In Capital: 37251800000.00
PPLPHARMA.NS balance_sheet (annual, 2022-03-31) — Allowance For Doubtful Accounts Receivable: -545200000.00
PPLPHARMA.NS balance_sheet (annual, 2022-03-31) — Buildings And Improvements: 11995900000.00
PPLPHARMA.NS cash_flow (annual, 2022-03-31) — Cash Dividends Paid: -500000000.00
PPLPHARMA.NS balance_sheet (annual, 2022-03-31) — Cash Financial: 2281000000.00
PPLPHARMA.NS balance_sheet (annual, 2022-03-31) — Current Deferred Taxes Liabilities: 716600000.00
PPLPHARMA.NS balance_sheet (annual, 2022-03-31) — Finished Goods: 3440400000.00
PPLPHARMA.NS income_statement (annual, 2022-03-31) — General And Administrative Expense: 1912100000.00
PPLPHARMA.NS balance_sheet (annual, 2022-03-31) — Gross Accounts Receivable: 18398000000.00
PPLPHARMA.NS balance_sheet (annual, 2022-03-31) — Hedging Assets Current: 74800000.00
PPLPHARMA.NS income_statement (annual, 2022-03-31) — Impairment Of Capital Assets: 0.00
PPLPHARMA.NS income_statement (annual, 2022-03-31) — Interest Income: 6800000.00
PPLPHARMA.NS income_statement (annual, 2022-03-31) — Interest Income Non Operating: 6800000.00
PPLPHARMA.NS cash_flow (annual, 2022-03-31) — Interest Received Cfi: 6800000.00
PPLPHARMA.NS balance_sheet (annual, 2022-03-31) — Investments In Other Ventures Under Equity Method: 1798200000.00
PPLPHARMA.NS balance_sheet (annual, 2022-03-31) — Investmentsin Associatesat Cost: 1056900000.00
PPLPHARMA.NS balance_sheet (annual, 2022-03-31) — Investmentsin Subsidiariesat Cost: 24915900000.00
PPLPHARMA.NS balance_sheet (annual, 2022-03-31) — Land And Improvements: 1337500000.00
PPLPHARMA.NS balance_sheet (annual, 2022-03-31) — Machinery Furniture Equipment: 30661700000.00
PPLPHARMA.NS cash_flow (annual, 2022-03-31) — Net Business Purchase And Sale: -9064500000.00
PPLPHARMA.NS cash_flow (annual, 2022-03-31) — Net Other Investing Changes: -100000.00
PPLPHARMA.NS cash_flow (annual, 2022-03-31) — Net Preferred Stock Issuance: 0.00
PPLPHARMA.NS balance_sheet (annual, 2022-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 107400000.00
PPLPHARMA.NS balance_sheet (annual, 2022-03-31) — Non Current Prepaid Assets: 892000000.00
PPLPHARMA.NS cash_flow (annual, 2022-03-31) — Other Cash Adjustment Outside Changein Cash: 767400000.00
PPLPHARMA.NS balance_sheet (annual, 2022-03-31) — Other Payable: 240800000.00
PPLPHARMA.NS balance_sheet (annual, 2022-03-31) — Other Receivables: 399600000.00
PPLPHARMA.NS balance_sheet (annual, 2022-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 1427900000.00
PPLPHARMA.NS cash_flow (annual, 2022-03-31) — Preferred Stock Issuance: 0.00
PPLPHARMA.NS balance_sheet (annual, 2022-03-31) — Prepaid Assets: 4663100000.00
PPLPHARMA.NS balance_sheet (annual, 2022-03-31) — Properties: 0.00
PPLPHARMA.NS cash_flow (annual, 2022-03-31) — Purchase Of Business: -9064500000.00
PPLPHARMA.NS balance_sheet (annual, 2022-03-31) — Raw Materials: 7223600000.00
PPLPHARMA.NS income_statement (annual, 2022-03-31) — Rent And Landing Fees: 282500000.00
PPLPHARMA.NS income_statement (annual, 2022-03-31) — Rent Expense Supplemental: 282500000.00
PPLPHARMA.NS income_statement (annual, 2022-03-31) — Research And Development: 1283400000.00
PPLPHARMA.NS balance_sheet (annual, 2022-03-31) — Restricted Cash: 56200000.00
PPLPHARMA.NS income_statement (annual, 2022-03-31) — Restructuring And Mergern Acquisition: 150800000.00
PPLPHARMA.NS balance_sheet (annual, 2022-03-31) — Retained Earnings: 8623800000.00
PPLPHARMA.NS income_statement (annual, 2022-03-31) — Selling And Marketing Expense: 2856200000.00
PPLPHARMA.NS income_statement (annual, 2022-03-31) — Selling General And Administration: 4768300000.00
PPLPHARMA.NS cash_flow (annual, 2022-03-31) — Short Term Debt Issuance: 13497200000.00
PPLPHARMA.NS cash_flow (annual, 2022-03-31) — Short Term Debt Payments: -9964700000.00
PPLPHARMA.NS income_statement (annual, 2022-03-31) — Total Other Finance Cost: 94700000.00
PPLPHARMA.NS balance_sheet (annual, 2022-03-31) — Tradeand Other Payables Non Current: 4000000.00
PPLPHARMA.NS balance_sheet (annual, 2022-03-31) — Work In Process: 3224000000.00
PPLPHARMA.NS income_statement (annual, 2022-03-31) — Write Off: 11600000.00
PPLPHARMA.NS income_statement (annual, 2023-03-31) — +Operating Expense: 40802000000.00
PPLPHARMA.NS income_statement (annual, 2023-03-31) — +Total Revenue: 70324100000.00
PPLPHARMA.NS balance_sheet (annual, 2023-03-31) — Accounts Payable: 11927100000.00
PPLPHARMA.NS balance_sheet (annual, 2023-03-31) — Accounts Receivable: 17993400000.00
PPLPHARMA.NS balance_sheet (annual, 2023-03-31) — Accumulated Depreciation: -19489300000.00
PPLPHARMA.NS balance_sheet (annual, 2023-03-31) — Allowance For Doubtful Accounts Receivable: -1034200000.00
PPLPHARMA.NS balance_sheet (annual, 2023-03-31) — Available For Sale Securities: 215500000.00
PPLPHARMA.NS income_statement (annual, 2023-03-31) — Basic Average Shares: 1212672645.00
PPLPHARMA.NS income_statement (annual, 2023-03-31) — Basic EPS: -1.54
PPLPHARMA.NS cash_flow (annual, 2023-03-31) — Beginning Cash Position: 851800000.00
PPLPHARMA.NS balance_sheet (annual, 2023-03-31) — Buildings And Improvements: 16241600000.00
PPLPHARMA.NS cash_flow (annual, 2023-03-31) — Capital Expenditure: -9647500000.00
PPLPHARMA.NS balance_sheet (annual, 2023-03-31) — Capital Lease Obligations: 1323100000.00
PPLPHARMA.NS balance_sheet (annual, 2023-03-31) — Capital Stock: 11933200000.00
PPLPHARMA.NS balance_sheet (annual, 2023-03-31) — Cash And Cash Equivalents: 1955900000.00
PPLPHARMA.NS balance_sheet (annual, 2023-03-31) — Cash Cash Equivalents And Short Term Investments: 6596500000.00
PPLPHARMA.NS cash_flow (annual, 2023-03-31) — Cash Dividends Paid: -670000000.00
PPLPHARMA.NS balance_sheet (annual, 2023-03-31) — Cash Financial: 1955900000.00
PPLPHARMA.NS cash_flow (annual, 2023-03-31) — Change In Inventory: -1726400000.00
PPLPHARMA.NS cash_flow (annual, 2023-03-31) — Change In Other Current Assets: 301400000.00
PPLPHARMA.NS cash_flow (annual, 2023-03-31) — Change In Other Current Liabilities: 199700000.00
PPLPHARMA.NS cash_flow (annual, 2023-03-31) — Change In Payable: -2716500000.00
PPLPHARMA.NS cash_flow (annual, 2023-03-31) — Change In Receivables: 892600000.00
PPLPHARMA.NS cash_flow (annual, 2023-03-31) — Change In Working Capital: -3020800000.00
PPLPHARMA.NS cash_flow (annual, 2023-03-31) — Changes In Cash: -371000000.00
PPLPHARMA.NS balance_sheet (annual, 2023-03-31) — Common Stock: 11933200000.00
PPLPHARMA.NS cash_flow (annual, 2023-03-31) — Common Stock Dividend Paid: -670000000.00
PPLPHARMA.NS balance_sheet (annual, 2023-03-31) — Common Stock Equity: 67735000000.00
PPLPHARMA.NS cash_flow (annual, 2023-03-31) — Common Stock Issuance: 0.00
PPLPHARMA.NS balance_sheet (annual, 2023-03-31) — Construction In Progress: 8529300000.00
PPLPHARMA.NS income_statement (annual, 2023-03-31) — Cost Of Revenue: 30001800000.00
PPLPHARMA.NS balance_sheet (annual, 2023-03-31) — Current Assets: 48354800000.00
PPLPHARMA.NS balance_sheet (annual, 2023-03-31) — Current Capital Lease Obligation: 303900000.00
PPLPHARMA.NS balance_sheet (annual, 2023-03-31) — Current Debt: 21212300000.00
PPLPHARMA.NS balance_sheet (annual, 2023-03-31) — Current Debt And Capital Lease Obligation: 21516200000.00
PPLPHARMA.NS balance_sheet (annual, 2023-03-31) — Current Deferred Taxes Liabilities: 35400000.00
PPLPHARMA.NS balance_sheet (annual, 2023-03-31) — Current Liabilities: 38430500000.00
PPLPHARMA.NS balance_sheet (annual, 2023-03-31) — Current Provisions: 392100000.00
PPLPHARMA.NS cash_flow (annual, 2023-03-31) — Depreciation: 6766900000.00
PPLPHARMA.NS cash_flow (annual, 2023-03-31) — Depreciation And Amortization: 6766900000.00
PPLPHARMA.NS income_statement (annual, 2023-03-31) — Depreciation And Amortization In Income Statement: 6766900000.00
PPLPHARMA.NS income_statement (annual, 2023-03-31) — Depreciation Income Statement: 6766900000.00
PPLPHARMA.NS income_statement (annual, 2023-03-31) — Diluted Average Shares: 1212672645.00
PPLPHARMA.NS income_statement (annual, 2023-03-31) — Diluted EPS: -1.54
PPLPHARMA.NS income_statement (annual, 2023-03-31) — Diluted NI Availto Com Stockholders: -1864600000.00
PPLPHARMA.NS cash_flow (annual, 2023-03-31) — Dividends Received Cfi: 754100000.00
PPLPHARMA.NS income_statement (annual, 2023-03-31) — EBIT: 2175600000.00
PPLPHARMA.NS income_statement (annual, 2023-03-31) — EBITDA: 8942500000.00
PPLPHARMA.NS cash_flow (annual, 2023-03-31) — Effect Of Exchange Rate Changes: 51500000.00
PPLPHARMA.NS cash_flow (annual, 2023-03-31) — End Cash Position: 532300000.00
PPLPHARMA.NS balance_sheet (annual, 2023-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 417600000.00
PPLPHARMA.NS cash_flow (annual, 2023-03-31) — Financing Cash Flow: 8177900000.00
PPLPHARMA.NS balance_sheet (annual, 2023-03-31) — Finished Goods: 4461900000.00
PPLPHARMA.NS cash_flow (annual, 2023-03-31) — Free Cash Flow: -4808600000.00
PPLPHARMA.NS cash_flow (annual, 2023-03-31) — Gain Loss On Investment Securities: -25600000.00
PPLPHARMA.NS cash_flow (annual, 2023-03-31) — Gain Loss On Sale Of PPE: 4800000.00
PPLPHARMA.NS income_statement (annual, 2023-03-31) — General And Administrative Expense: 2316900000.00
PPLPHARMA.NS balance_sheet (annual, 2023-03-31) — Goodwill: 11075100000.00
PPLPHARMA.NS balance_sheet (annual, 2023-03-31) — Goodwill And Other Intangible Assets: 44457300000.00
PPLPHARMA.NS balance_sheet (annual, 2023-03-31) — Gross Accounts Receivable: 19027600000.00
PPLPHARMA.NS balance_sheet (annual, 2023-03-31) — Gross PPE: 63903700000.00
PPLPHARMA.NS income_statement (annual, 2023-03-31) — Gross Profit: 40322300000.00
PPLPHARMA.NS balance_sheet (annual, 2023-03-31) — Hedging Assets Current: 231600000.00
PPLPHARMA.NS income_statement (annual, 2023-03-31) — Interest Expense: 3377100000.00
PPLPHARMA.NS income_statement (annual, 2023-03-31) — Interest Expense Non Operating: 3377100000.00
PPLPHARMA.NS income_statement (annual, 2023-03-31) — Interest Income: 16400000.00
PPLPHARMA.NS income_statement (annual, 2023-03-31) — Interest Income Non Operating: 16400000.00
PPLPHARMA.NS cash_flow (annual, 2023-03-31) — Interest Paid Cff: -2781200000.00
PPLPHARMA.NS cash_flow (annual, 2023-03-31) — Interest Received Cfi: 0.00
PPLPHARMA.NS balance_sheet (annual, 2023-03-31) — Inventory: 16813700000.00
PPLPHARMA.NS balance_sheet (annual, 2023-03-31) — Invested Capital: 122782700000.00
PPLPHARMA.NS cash_flow (annual, 2023-03-31) — Investing Cash Flow: -13387800000.00
PPLPHARMA.NS balance_sheet (annual, 2023-03-31) — Investmentin Financial Assets: 417600000.00
PPLPHARMA.NS balance_sheet (annual, 2023-03-31) — Investments In Other Ventures Under Equity Method: 1701100000.00
PPLPHARMA.NS cash_flow (annual, 2023-03-31) — Issuance Of Capital Stock: 0.00
PPLPHARMA.NS cash_flow (annual, 2023-03-31) — Issuance Of Debt: 43846700000.00
PPLPHARMA.NS balance_sheet (annual, 2023-03-31) — Land And Improvements: 2613400000.00
PPLPHARMA.NS balance_sheet (annual, 2023-03-31) — Long Term Capital Lease Obligation: 1019200000.00
PPLPHARMA.NS balance_sheet (annual, 2023-03-31) — Long Term Debt: 33835400000.00
PPLPHARMA.NS balance_sheet (annual, 2023-03-31) — Long Term Debt And Capital Lease Obligation: 34854600000.00
PPLPHARMA.NS cash_flow (annual, 2023-03-31) — Long Term Debt Issuance: 25628100000.00
PPLPHARMA.NS cash_flow (annual, 2023-03-31) — Long Term Debt Payments: -17215300000.00
PPLPHARMA.NS balance_sheet (annual, 2023-03-31) — Long Term Equity Investment: 1701100000.00
PPLPHARMA.NS balance_sheet (annual, 2023-03-31) — Long Term Provisions: 206800000.00
PPLPHARMA.NS balance_sheet (annual, 2023-03-31) — Machinery Furniture Equipment: 36519400000.00
PPLPHARMA.NS cash_flow (annual, 2023-03-31) — Net Business Purchase And Sale: -203500000.00
PPLPHARMA.NS cash_flow (annual, 2023-03-31) — Net Common Stock Issuance: 0.00
PPLPHARMA.NS balance_sheet (annual, 2023-03-31) — Net Debt: 53091800000.00
PPLPHARMA.NS cash_flow (annual, 2023-03-31) — Net Foreign Currency Exchange Gain Loss: 715600000.00
PPLPHARMA.NS income_statement (annual, 2023-03-31) — Net Income: -1864600000.00
PPLPHARMA.NS income_statement (annual, 2023-03-31) — Net Income Common Stockholders: -1864600000.00
PPLPHARMA.NS income_statement (annual, 2023-03-31) — Net Income Continuous Operations: -1864600000.00
PPLPHARMA.NS income_statement (annual, 2023-03-31) — Net Income From Continuing And Discontinued Operation: -1864600000.00
PPLPHARMA.NS income_statement (annual, 2023-03-31) — Net Income From Continuing Operation Net Minority Interest: -1864600000.00
PPLPHARMA.NS cash_flow (annual, 2023-03-31) — Net Income From Continuing Operations: -1605600000.00
PPLPHARMA.NS income_statement (annual, 2023-03-31) — Net Income Including Noncontrolling Interests: -1864600000.00
PPLPHARMA.NS income_statement (annual, 2023-03-31) — Net Interest Income: -3425400000.00
PPLPHARMA.NS cash_flow (annual, 2023-03-31) — Net Investment Purchase And Sale: -3754700000.00
PPLPHARMA.NS cash_flow (annual, 2023-03-31) — Net Issuance Payments Of Debt: 11984200000.00
PPLPHARMA.NS cash_flow (annual, 2023-03-31) — Net Long Term Debt Issuance: 8412800000.00
PPLPHARMA.NS income_statement (annual, 2023-03-31) — Net Non Operating Interest Income Expense: -3425400000.00
PPLPHARMA.NS cash_flow (annual, 2023-03-31) — Net Other Investing Changes: -733100000.00
PPLPHARMA.NS balance_sheet (annual, 2023-03-31) — Net PPE: 44414400000.00
PPLPHARMA.NS cash_flow (annual, 2023-03-31) — Net PPE Purchase And Sale: -9450600000.00
PPLPHARMA.NS cash_flow (annual, 2023-03-31) — Net Short Term Debt Issuance: 3571400000.00
PPLPHARMA.NS balance_sheet (annual, 2023-03-31) — Net Tangible Assets: 23277700000.00
PPLPHARMA.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Revenue: 1755800000.00
PPLPHARMA.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Taxes Assets: 3493000000.00
PPLPHARMA.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Taxes Liabilities: 2193100000.00
PPLPHARMA.NS balance_sheet (annual, 2023-03-31) — Non Current Prepaid Assets: 2368700000.00
PPLPHARMA.NS income_statement (annual, 2023-03-31) — Normalized EBITDA: 8991300000.00
PPLPHARMA.NS income_statement (annual, 2023-03-31) — Normalized Income: -1830440000.00
PPLPHARMA.NS cash_flow (annual, 2023-03-31) — Operating Cash Flow: 4838900000.00
PPLPHARMA.NS income_statement (annual, 2023-03-31) — Operating Income: -479700000.00
PPLPHARMA.NS income_statement (annual, 2023-03-31) — Operating Revenue: 70324100000.00
PPLPHARMA.NS balance_sheet (annual, 2023-03-31) — Ordinary Shares Number: 1217091928.00
PPLPHARMA.NS balance_sheet (annual, 2023-03-31) — Other Current Assets: 5276800000.00
PPLPHARMA.NS balance_sheet (annual, 2023-03-31) — Other Current Liabilities: 255500000.00
PPLPHARMA.NS balance_sheet (annual, 2023-03-31) — Other Equity Interest: 55801800000.00
PPLPHARMA.NS balance_sheet (annual, 2023-03-31) — Other Intangible Assets: 33382200000.00
PPLPHARMA.NS balance_sheet (annual, 2023-03-31) — Other Investments: 417600000.00
PPLPHARMA.NS cash_flow (annual, 2023-03-31) — Other Non Cash Items: 3033400000.00
PPLPHARMA.NS balance_sheet (annual, 2023-03-31) — Other Non Current Assets: 100000.00
PPLPHARMA.NS balance_sheet (annual, 2023-03-31) — Other Non Current Liabilities: 1755800000.00